Chris Kallos, CFA, is a healthcare and biotech equities analyst with over 20 years experience in both Australian and US stocks. He has covered small, medium and large cap stocks for a range of research houses in Australia, the United Kingdom and the United States. Chris holds a Bachelor of Pharmacy (Sydney), an MBA from the AGSM (UNSW), and a Masters of Applied Finance (Macquarie). He is a CFA charterholder and graduate of the Australian Institute of Company Directors.
Download links are only valid for a limited time. Please click the refresh button.
All material on this website has been prepared by MST Access Services Pty Limited (ABN 54 617 475 180, AFSL 500 557), for general informational purposes only and is not a solicitation of any offer to buy or sell any financial instrument or to participate in any trading strategy. Unless otherwise stated, the material presented on this site is not a research report as defined under ASIC guidance.
For wholesale clients only
This material is only prepared for wholesale clients pursuant to section 761G(7) of the Corporations Act (Commonwealth).